Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar by Meijboom, Rosanne W., Gardarsdottir, Helga, Becker, Matthijs L., Movig, Kris L. L., Kuijvenhoven, Johan, Egberts, Toine C. G., Giezen, Thijs J.

Get full text

Switching TNFα inhibitors: Patterns and determinants by Meijboom, Rosanne W., Gardarsdottir, Helga, Becker, Matthijs L., de Groot, Mark C. H., Movig, Kris L. L., Kuijvenhoven, Johan, Egberts, Toine C. G., Leufkens, Hubert G. M., Giezen, Thijs J.

Get full text

Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review by Meijboom, Rosanne W., Gardarsdottir, Helga, Egberts, Toine C. G., Giezen, Thijs J.

Get full text

Dispensability of Annual Laboratory Follow-Up After More than 2 Years of Valproic Acid Use: A Systematic Review by Meijboom, Rosanne W., Grootens, Koen P.

Get full text

Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept by Meijboom, Rosanne W., Gardarsdottir, Helga, Becker, Matthijs L., ten Wolde, Saskia, Egberts, Toine C. G., Giezen, Thijs J.

Get full text

Clinical Course Long After Atrial Switch: A Novel Risk Score for Major Clinical Events by Woudstra, Odilia I, Zandstra, Tjitske E, Vogel, Rosanne F, van Dijk, Arie P J, Vliegen, Hubert W, Kiès, Philippine, Jongbloed, Monique R M, Egorova, Anastasia D, Doevendans, Pieter A F M, Konings, Thelma C, Mulder, Barbara J M, Tanck, Michael W T, Meijboom, Folkert J, Bouma, Berto J

Get full text